The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
European Medicines Agency is looking at approving lazertinib, in combination with amivantamab, for the first-line treatment of patients with EGFR-mutated NSCLC
The Janssen Pharmaceutical Companies of Johnston & Johnson announced the submission of a marketing authorisation application…